GlobalData on MSN6d
Abcuro secures $200m as it eyes approval for rare muscle disease drug
The funding will be used to complete the Phase II/III trial of ulviprubart, and to support commercial launch preparation.
Nature25d
Equine Atypical Myopathy and Hypoglycin A Toxicity
Equine atypical myopathy (EAM) is a serious and often fatal ... may be less susceptible to its toxic effects. This suggests that the digestive processes in these animals could mitigate the impact ...